Click for best price
Cancer Biological Toxins Drug Market Size, Share 2023
Treatment of cancer disease depends on the stage of disease progression. Chemotherapy is widely used in earlier stages but there are other therapy options like immunological therapy and targeted drugs used in later stages.
This report aims to provide a comprehensive presentation of the global market for Cancer Biological Toxins Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biological Toxins Drug. This report contains market size and forecasts of Cancer Biological Toxins Drug in global, including the following market information:
Global Cancer Biological Toxins Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Biological Toxins Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hormonal Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Biological Toxins Drug include Amgen Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Celgene Corporation, Exelixis, Inc., Merck, Pfizer Inc, and Sanofi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Biological Toxins Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Biological Toxins Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biological Toxins Drug Market Segment Percentages, by Type, 2022 (%)
Hormonal Therapy
Immunotherapy
Targeted Therapy
Global Cancer Biological Toxins Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Biological Toxins Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Laboratory
Others
Global Cancer Biological Toxins Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Biological Toxins Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Biological Toxins Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Biological Toxins Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc.
AstraZeneca PLC
Bayer AG
Bristol-Myers Squibb Company
Celgene Corporation
Exelixis, Inc.
Merck
Pfizer Inc,
Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Biological Toxins Drug, market overview.
Chapter 2: Global Cancer Biological Toxins Drug market size in revenue.
Chapter 3: Detailed analysis of Cancer Biological Toxins Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Biological Toxins Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cancer Biological Toxins Drug Market Professional Survey, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Biological Toxins Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Biological Toxins Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Biological Toxins Drug Overall Market Size
2.1 Global Cancer Biological Toxins Drug Market Size: 2022 VS 2029
2.2 Global Cancer Biological Toxins Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Biological Toxins Drug Players in Global Market
3.2 Top Global Cancer Biological Toxins Drug Companies Ranked by Revenue
3.3 Global Cancer Biological Toxins Drug Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biological Toxins Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Biological Toxins Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biological Toxins Drug Players in Global Market
3.6.1 List of Global Tier 1 Cancer Biological Toxins Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Biological Toxins Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Biological Toxins Drug Market Size Markets, 2022 & 2029
4.1.2 Hormonal Therapy
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.2 By Type - Global Cancer Biological Toxins Drug Revenue & Forecasts
4.2.1 By Type - Global Cancer Biological Toxins Drug Revenue, 2018-2023
4.2.2 By Type - Global Cancer Biological Toxins Drug Revenue, 2024-2029
4.2.3 By Type - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Biological Toxins Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Others
5.2 By Application - Global Cancer Biological Toxins Drug Revenue & Forecasts
5.2.1 By Application - Global Cancer Biological Toxins Drug Revenue, 2018-2023
5.2.2 By Application - Global Cancer Biological Toxins Drug Revenue, 2024-2029
5.2.3 By Application - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Biological Toxins Drug Market Size, 2022 & 2029
6.2 By Region - Global Cancer Biological Toxins Drug Revenue & Forecasts
6.2.1 By Region - Global Cancer Biological Toxins Drug Revenue, 2018-2023
6.2.2 By Region - Global Cancer Biological Toxins Drug Revenue, 2024-2029
6.2.3 By Region - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Biological Toxins Drug Revenue, 2018-2029
6.3.2 US Cancer Biological Toxins Drug Market Size, 2018-2029
6.3.3 Canada Cancer Biological Toxins Drug Market Size, 2018-2029
6.3.4 Mexico Cancer Biological Toxins Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Biological Toxins Drug Revenue, 2018-2029
6.4.2 Germany Cancer Biological Toxins Drug Market Size, 2018-2029
6.4.3 France Cancer Biological Toxins Drug Market Size, 2018-2029
6.4.4 U.K. Cancer Biological Toxins Drug Market Size, 2018-2029
6.4.5 Italy Cancer Biological Toxins Drug Market Size, 2018-2029
6.4.6 Russia Cancer Biological Toxins Drug Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Biological Toxins Drug Market Size, 2018-2029
6.4.8 Benelux Cancer Biological Toxins Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Biological Toxins Drug Revenue, 2018-2029
6.5.2 China Cancer Biological Toxins Drug Market Size, 2018-2029
6.5.3 Japan Cancer Biological Toxins Drug Market Size, 2018-2029
6.5.4 South Korea Cancer Biological Toxins Drug Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Biological Toxins Drug Market Size, 2018-2029
6.5.6 India Cancer Biological Toxins Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Biological Toxins Drug Revenue, 2018-2029
6.6.2 Brazil Cancer Biological Toxins Drug Market Size, 2018-2029
6.6.3 Argentina Cancer Biological Toxins Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue, 2018-2029
6.7.2 Turkey Cancer Biological Toxins Drug Market Size, 2018-2029
6.7.3 Israel Cancer Biological Toxins Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Biological Toxins Drug Market Size, 2018-2029
6.7.5 UAE Cancer Biological Toxins Drug Market Size, 2018-2029
7 Cancer Biological Toxins Drug Companies Profiles
7.1 Amgen Inc.
7.1.1 Amgen Inc. Company Summary
7.1.2 Amgen Inc. Business Overview
7.1.3 Amgen Inc. Cancer Biological Toxins Drug Major Product Offerings
7.1.4 Amgen Inc. Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.1.5 Amgen Inc. Key News & Latest Developments
7.2 AstraZeneca PLC
7.2.1 AstraZeneca PLC Company Summary
7.2.2 AstraZeneca PLC Business Overview
7.2.3 AstraZeneca PLC Cancer Biological Toxins Drug Major Product Offerings
7.2.4 AstraZeneca PLC Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca PLC Key News & Latest Developments
7.3 Bayer AG
7.3.1 Bayer AG Company Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Cancer Biological Toxins Drug Major Product Offerings
7.3.4 Bayer AG Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.3.5 Bayer AG Key News & Latest Developments
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Company Summary
7.4.2 Bristol-Myers Squibb Company Business Overview
7.4.3 Bristol-Myers Squibb Company Cancer Biological Toxins Drug Major Product Offerings
7.4.4 Bristol-Myers Squibb Company Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation Cancer Biological Toxins Drug Major Product Offerings
7.5.4 Celgene Corporation Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 Exelixis, Inc.
7.6.1 Exelixis, Inc. Company Summary
7.6.2 Exelixis, Inc. Business Overview
7.6.3 Exelixis, Inc. Cancer Biological Toxins Drug Major Product Offerings
7.6.4 Exelixis, Inc. Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.6.5 Exelixis, Inc. Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Cancer Biological Toxins Drug Major Product Offerings
7.7.4 Merck Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Pfizer Inc,
7.8.1 Pfizer Inc, Company Summary
7.8.2 Pfizer Inc, Business Overview
7.8.3 Pfizer Inc, Cancer Biological Toxins Drug Major Product Offerings
7.8.4 Pfizer Inc, Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.8.5 Pfizer Inc, Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Cancer Biological Toxins Drug Major Product Offerings
7.9.4 Sanofi Cancer Biological Toxins Drug Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Biological Toxins Drug Market Opportunities & Trends in Global Market
Table 2. Cancer Biological Toxins Drug Market Drivers in Global Market
Table 3. Cancer Biological Toxins Drug Market Restraints in Global Market
Table 4. Key Players of Cancer Biological Toxins Drug in Global Market
Table 5. Top Cancer Biological Toxins Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Biological Toxins Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Biological Toxins Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Biological Toxins Drug Product Type
Table 9. List of Global Tier 1 Cancer Biological Toxins Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biological Toxins Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Biological Toxins Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Biological Toxins Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Biological Toxins Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Biological Toxins Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Biological Toxins Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Inc. Company Summary
Table 31. Amgen Inc. Cancer Biological Toxins Drug Product Offerings
Table 32. Amgen Inc. Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Inc. Key News & Latest Developments
Table 34. AstraZeneca PLC Company Summary
Table 35. AstraZeneca PLC Cancer Biological Toxins Drug Product Offerings
Table 36. AstraZeneca PLC Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca PLC Key News & Latest Developments
Table 38. Bayer AG Company Summary
Table 39. Bayer AG Cancer Biological Toxins Drug Product Offerings
Table 40. Bayer AG Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Bayer AG Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Company Summary
Table 43. Bristol-Myers Squibb Company Cancer Biological Toxins Drug Product Offerings
Table 44. Bristol-Myers Squibb Company Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Company Key News & Latest Developments
Table 46. Celgene Corporation Company Summary
Table 47. Celgene Corporation Cancer Biological Toxins Drug Product Offerings
Table 48. Celgene Corporation Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Corporation Key News & Latest Developments
Table 50. Exelixis, Inc. Company Summary
Table 51. Exelixis, Inc. Cancer Biological Toxins Drug Product Offerings
Table 52. Exelixis, Inc. Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Exelixis, Inc. Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Cancer Biological Toxins Drug Product Offerings
Table 56. Merck Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Pfizer Inc, Company Summary
Table 59. Pfizer Inc, Cancer Biological Toxins Drug Product Offerings
Table 60. Pfizer Inc, Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Inc, Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Cancer Biological Toxins Drug Product Offerings
Table 64. Sanofi Cancer Biological Toxins Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Cancer Biological Toxins Drug Segment by Type in 2022
Figure 2. Cancer Biological Toxins Drug Segment by Application in 2022
Figure 3. Global Cancer Biological Toxins Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Biological Toxins Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Biological Toxins Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Biological Toxins Drug Revenue in 2022
Figure 8. By Type - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Biological Toxins Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 16. US Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 28. China Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Biological Toxins Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Biological Toxins Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Inc. Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca PLC Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bayer AG Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Company Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Corporation Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Exelixis, Inc. Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Inc, Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sanofi Cancer Biological Toxins Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
